172 related articles for article (PubMed ID: 57934)
1. Ability of delayed-type hypersensitivity reactions to distinguish tumor-associated antigens and histocompatibility antigens in soluble extracts from murine fibrosarcomas.
Kon ND; Forbes JT; Klein PA
Int J Cancer; 1976 May; 17(5):613-20. PubMed ID: 57934
[TBL] [Abstract][Full Text] [Related]
2. Measurement of H-2 and non-H-2 antigens in the mouse with the footpad swelling test.
Kon ND; Klein PA
J Immunol; 1976 Aug; 117(2):413-5. PubMed ID: 781129
[TBL] [Abstract][Full Text] [Related]
3. Delayed hypersensitivity to crude and partially purified murine tumor-specific transplantation antigens and alloantigens utilizing the footpad swelling assay.
Macek CM; Kahan BD; Pellis NR
J Immunol; 1980 Oct; 125(4):1639-43. PubMed ID: 6157743
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
5. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
Svoboda I; Măzuran R; Rabatić S; Silobrcić
Int J Cancer; 1977 Mar; 19(3):371-7. PubMed ID: 844913
[TBL] [Abstract][Full Text] [Related]
6. In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.
Burton RC; Warner NL
Br J Cancer; 1978 Feb; 37(2):159-70. PubMed ID: 75739
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
8. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas.
Ogata M; Shimizu J; Kosaka H; Maekawa R; Shimizu K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Nov; 77(11):1134-41. PubMed ID: 3098723
[TBL] [Abstract][Full Text] [Related]
9. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
Chauvenet PH; Smith RT
Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
LeGrue SJ; Pellis NR; Riley LB; Kahan BD
Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
[TBL] [Abstract][Full Text] [Related]
11. Specificity of cell membrane antigens in prostatic cancer.
Brannen GE; Gomolka DM; Coffey DS
Cancer Chemother Rep; 1975; 59(1):127-38. PubMed ID: 1131799
[TBL] [Abstract][Full Text] [Related]
12. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
Frbes JT; Nakaw Y; Smith RT
J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
[TBL] [Abstract][Full Text] [Related]
13. Expression of alien H-2 specificities of a chemically induced BALB/c fibrosarcoma.
Meschini A; Invernizzi G; Parmiami G
Int J Cancer; 1977 Aug; 20(2):271-83. PubMed ID: 70414
[TBL] [Abstract][Full Text] [Related]
14. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells.
Moriuchi T
Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to soluble tumor antigens in various stages of tumor growth.
Brannen GE; Santos GW
Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma.
Minami A; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
Int J Cancer; 1979 Mar; 23(3):358-65. PubMed ID: 437918
[TBL] [Abstract][Full Text] [Related]
17. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content.
Beissert S; Ullrich SE; Hosoi J; Granstein RD
J Leukoc Biol; 1995 Aug; 58(2):234-40. PubMed ID: 7643016
[TBL] [Abstract][Full Text] [Related]
18. Analysis of immunosuppressor cells induced by immunization of solubilized tumor-associated antigens prepared from a rat fibrosarcoma.
Minami A
Nihon Seikeigeka Gakkai Zasshi; 1981 Aug; 55(8):779-92. PubMed ID: 6171602
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assay.
Hellström I; Hellström KE; Shantz G
Int J Cancer; 1976 Sep; 18(3):354-61. PubMed ID: 955746
[TBL] [Abstract][Full Text] [Related]
20. Genetic control of in vivo immunity to tumor-specific transplantation antigens of chemically induced murine fibrosarcomas.
Parmiani G; Ballinari D
Int J Cancer; 1979 May; 23(5):697-705. PubMed ID: 88423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
